Accrol Group Holdings PLC Notice: Results, Strategic Review & Presentations (2922M)

TIDMACRL

RNS Number : 2922M

Accrol Group Holdings PLC

11 January 2023

11 January 2023

ACCROL GROUP HOLDINGS PLC

("Accrol" or the "Group")

AIM: ACRL

Notice of Half Year Results, Outcomes of Strategic Review, and Online Presentations

Accrol, the UK's leading independent tissue converter, announces that it will release its Half Year Results for the six months ended 31 October 2022, alongside the outcomes of the Strategic Review, on Tuesday, 24 January 2023.

An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.

As part of the Group's Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Friday, 27 January at 12.30pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_H123_results_webinar.

For further information, please contact:

 
 Accrol Group Holdings plc                  Via Belvedere Communications 
  Dan Wright, Executive Chairman 
  Gareth Jenkins, Chief Executive Officer 
  Richard Newman, Chief Financial Officer 
 Zeus (Nominated Adviser & Broker) 
  Dan Bate / Jordan Warburton (Investment           Tel: [phone] 
  Banking)                                                          1512 
  Dominic King (Corporate Broking)                  Tel: [phone] 
                                                                    5000 
 Liberum Capital Limited (Joint Broker) 
  Clayton Bush / Edward Thomas                      Tel: [phone] 
                                                                    2222 
 Belvedere Communications Limited 
  Cat Valentine                                    Tel: [phone] 
  Keeley Clarke                                                      078 
                                                   Tel: [phone] 
                                                                     525 
                                                [e-mail] 
 

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which now supplies 21.5% (volume) of the UK tissue market valued at GBP2.1bn at retail sales value.

The Group has produced a short video to showcase its operations and investment in the extensive automation of the business. Click here: Accrol Today.

For more information, please visit www.accrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORGZGMMVGMGFZM

(END) Dow Jones Newswires

January 11, 2023 02:00 ET (07:00 GMT)